520 related articles for article (PubMed ID: 27768763)
1. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
[TBL] [Abstract][Full Text] [Related]
2. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
4. CGG-repeat dynamics and
Zhou Y; Kumari D; Sciascia N; Usdin K
Mol Autism; 2016; 7():42. PubMed ID: 27713816
[TBL] [Abstract][Full Text] [Related]
5. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene.
Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R
Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084
[TBL] [Abstract][Full Text] [Related]
6. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
[TBL] [Abstract][Full Text] [Related]
7. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Sølvsten C; Nielsen AL
Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
[TBL] [Abstract][Full Text] [Related]
8. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.
Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O
Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363
[TBL] [Abstract][Full Text] [Related]
9. Establishment of FXS-A9 panel with a single human X chromosome from fragile X syndrome-associated individual.
Nakayama Y; Adachi K; Shioda N; Maeta S; Nanba E; Kugoh H
Exp Cell Res; 2021 Jan; 398(2):112419. PubMed ID: 33296661
[TBL] [Abstract][Full Text] [Related]
10. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome.
Meijer H; de Graaff E; Merckx DM; Jongbloed RJ; de Die-Smulders CE; Engelen JJ; Fryns JP; Curfs PM; Oostra BA
Hum Mol Genet; 1994 Apr; 3(4):615-20. PubMed ID: 8069307
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.
Todd PK; Oh SY; Krans A; Pandey UB; Di Prospero NA; Min KT; Taylor JP; Paulson HL
PLoS Genet; 2010 Dec; 6(12):e1001240. PubMed ID: 21170301
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic variability to medication management: an update on fragile X syndrome.
Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA
Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260
[TBL] [Abstract][Full Text] [Related]
13. Use of human-derived stem cells to create a novel, in vitro model designed to explore FMR1 CGG repeat instability amongst female premutation carriers.
Gustin SLF; Wang G; Baker VM; Latham G; Sebastiano V
J Assist Reprod Genet; 2018 Aug; 35(8):1443-1455. PubMed ID: 29926373
[TBL] [Abstract][Full Text] [Related]
14. Site-specific R-loops induce CGG repeat contraction and fragile X gene reactivation.
Lee HG; Imaichi S; Kraeutler E; Aguilar R; Lee YW; Sheridan SD; Lee JT
Cell; 2023 Jun; 186(12):2593-2609.e18. PubMed ID: 37209683
[TBL] [Abstract][Full Text] [Related]
15. Small Molecules Targeting H3K9 Methylation Prevent Silencing of Reactivated
Kumari D; Sciascia N; Usdin K
Genes (Basel); 2020 Mar; 11(4):. PubMed ID: 32230785
[TBL] [Abstract][Full Text] [Related]
16. [Chromatin changes caused by CGG repeat expansion in fmr1 gene].
Yudkin DV; Lemskaya NA; Grischenko IV; Dolskiy AA
Mol Biol (Mosk); 2015; 49(2):205-11. PubMed ID: 26065250
[TBL] [Abstract][Full Text] [Related]
17. Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.
Colak D; Zaninovic N; Cohen MS; Rosenwaks Z; Yang WY; Gerhardt J; Disney MD; Jaffrey SR
Science; 2014 Feb; 343(6174):1002-5. PubMed ID: 24578575
[TBL] [Abstract][Full Text] [Related]
18. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
19. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.
Brouwer JR; Mientjes EJ; Bakker CE; Nieuwenhuizen IM; Severijnen LA; Van der Linde HC; Nelson DL; Oostra BA; Willemsen R
Exp Cell Res; 2007 Jan; 313(2):244-53. PubMed ID: 17150213
[TBL] [Abstract][Full Text] [Related]
20. Human pluripotent stem cell models of Fragile X syndrome.
Bhattacharyya A; Zhao X
Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
